Skip to main content
SpringerLink
Log in

Liposomal form of Dexamethasone in Experimental Autoimmune Uveitis: Clinical and Immunological Effects

  • Published:
Pharmaceutical Chemistry Journal Aims and scope

The effectiveness of liposomal dexamethasone in experimental autoimmune uveitis in rabbits was studied. An original liposomal form of dexamethasone and its official aqueous solution were compared. The liposomal composition consisted of vesicles 124 ± 6 mm in size with an active substance concentration of 4 mg/mL. The official aqueous solution of dexamethasone was used in the positive control group. The study was performed on chinchilla rabbits with an endotoxin-induced anterior uveitis model. The animals were divided into three groups: control (untreated), treatment with water-soluble dexamethasone, and treatment with the liposomal form of dexamethasone. The drugs were administered once subconjunctivally at the peak of clinical manifestations of uveitis. The clinical presentation and scoring criterion for the severity of uveitis and some hematological and immunological parameters were assessed. The severity of clinical symptoms of uveitis decreased during the treatment. There were no significant differences between the clinical efficacies of the studied drugs 72 hours after the start of therapy. There was a more pronounced clinical improvement and a decrease in systemic inflammation in the liposomal dexamethasone group on the 10th day after the start of therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.
Fig. 3.

Similar content being viewed by others

References

  1. S. D. Anesi and C. S. Foster, Adv. Ocular Care, Jan-Feb, 32 – 34 (2011).

  2. P. N. Dayani, Adv. Ocular Care, 1, 32 – 34 (2011).

    Google Scholar 

  3. A. N. Trunov, Vestn. Orenburg. Gos. Univ., No. 4, 270 – 274 (2013).

  4. N. M. Maracheva, Vestn. Yuzhno-Ural. Gos. Univ., No. 37, 72 – 75 (2010).

  5. I. F. Gutteridge and A. J. Hall, Clin. Exp. Optom., 90(2), 70 – 82 (2007).

    Article  PubMed  Google Scholar 

  6. M. R. Guseva, Ross. Det. Oftal?mol., No. 1, 22 – 25 (2013).

  7. K. Julian, Ocul. Immunol. Inflammation, 3, 172 – 177 (2010).

    Article  Google Scholar 

  8. N. B. Chesnokova, L. A. Katargina, and T. P. Kuznetsova, Antioxidant Activity of Tears in Prognosis of Treatment of Endogenic Uveitis: Physicians Guide [in Russian], Moskovskii NII Glaznykh Boleznei im. Gel’mgol’tsa, Moscow (2003).

    Google Scholar 

  9. L. A. Katsnel’son and V. E. Tankovskii, Uveitis (Clinic, Treatment) [in Russian], 4th Filial Voenizdata, Moscow (2003).

  10. L. A. Katargina and A. V. Khvatova, Endogenic Uveitis in Children and Adolescents [in Russian], Meditsina, Moscow (2000).

    Google Scholar 

  11. C. Munz, J. D. Lunemann, M. T. Getts, et al., Nat. Rev. Immunol., 9(4), 246 – 258 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  12. M. T. Getts and S. D. Miller, Clin. Exp. Immunol., 160(1), 15 – 21 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. E. A. Egorov, Rational Pharmacotherapy in Ophthalmology [in Russian], Litterra, Moscow (2004).

    Google Scholar 

  14. V. L. Perez and R. R. Caspi, Trends Immunol., 6, 354 – 363 (2015).

    Article  Google Scholar 

  15. J. C. Ten Berge, M. W. J. Schreurs, P. L. A. van Daele, et al., Acta Ophthalmol., 96(5), 481 – 485 (2018).

    Article  PubMed  Google Scholar 

  16. X. Wen, X. Hu, L. Miao, et al., Eye Res., 64, 84 – 95 (2018).

    CAS  Google Scholar 

  17. D. K. Ingawale and S. K. Mandlik, Immunopharmacol. Immunotoxicol., 42(2), 59 – 73 (2020).

    Article  CAS  PubMed  Google Scholar 

  18. S. F. Sorrells and R. M. Sapolsky, Brain, Behav., Immun., 21(3), 259 – 272 (2007).

  19. D. Cruz-Topete and J. A. Cidlowski, NeuroImmunoModulation, 22, 20 – 32 (2015).

    Article  CAS  PubMed  Google Scholar 

  20. M. Oray, K. Abu Samra, N. Ebrahimiadib, et al., Expert Opin. Drug Saf., 15(4), 457 – 465 (2016).

  21. A. Caplan, N. Fett, M. Rosenbach, et al., J. Am. Acad. Dermatol., 76(1), 11 – 16 (2017).

    Article  PubMed  Google Scholar 

  22. A. Balla, M. Ruponen, A. Valtari, et al., Eur. J. Pharm. Biopharm., 172, 53 – 60 (2022).

    Article  CAS  PubMed  Google Scholar 

  23. H. K. Ibrahim, I. S. El-Leithy, and A. A. Makky, Mol. Pharmaceutics, 7(2), 576 – 585 (2010).

    Article  CAS  Google Scholar 

  24. E. Wolska and M. Brach, Pharmaceutics, 14(2), 335 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. J. Zhao, Y. Cui, A. Wang, et al., Langmuir, 27(4), 1499 – 1504 (2011).

    Article  CAS  PubMed  Google Scholar 

  26. O. A. Kulikov, D. V. Yunina, V. P. Ageev, et al., Khim.-farm. Zh., 56(12), 23 – 26 (2022).

    Google Scholar 

  27. J. T. Rosenbaum, H. L. Rosenzweig, R. Justine, et al., Ophthalmic Res., 40(3 – 4), 165 – 168 (2008).

    Article  PubMed  Google Scholar 

  28. O. A. Kulikov, A. V. Zaborovskii, D. V. Yunina, et al., Chel. Ego Zdorov’e, 24(3), 39 – 49 (2021).

    Google Scholar 

  29. O. A. Kulikov, Vopr. Biol., Med. Farm. Khim., 20(6), 24 – 27 (2017).

  30. S. V. Aksenova, N. A. Pyataev, M. V. Mal’kina, and N. V. Lakshtankina, Vestn. Mordov. Univ., 27(3), 428 – 439 (2017).

  31. B. H. Park, J. Pediatr., 78(2), 376 – 378 (1971).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Research Ogarev Mordovia State University, 68 Bol’shevistskaya St., Saransk, 430005, Russia

    S. V. Aksenova, M. V. Malkina, E. A. Khozina, V. I. Shlyapkina, O. A. Kulikov & N. A. Pyataev

  2. A. I. Yevdokimov Moscow State University of Medicine and Dentistry, Ministry of Healthcare of the Russian Federation, 20/1 Delegatskaya St., Moscow, 127473, Russia

    A. V. Zaborovskii, D. V. Yunina & L. A. Tararina

Authors
  1. S. V. Aksenova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. V. Malkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. V. Zaborovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. V. Yunina
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. A. Tararina
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. A. Khozina
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. I. Shlyapkina
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. O. A. Kulikov
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. N. A. Pyataev
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. V. Zaborovskii.

Additional information

Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 57, No. 8, pp. 9 – 14, August, 2023.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aksenova, S.V., Malkina, M.V., Zaborovskii, A.V. et al. Liposomal form of Dexamethasone in Experimental Autoimmune Uveitis: Clinical and Immunological Effects. Pharm Chem J 57, 1153–1158 (2023). https://doi.org/10.1007/s11094-024-03020-5

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11094-024-03020-5

Keywords

Search

Navigation